Modeling ALS and FTD with iPSC-derived neurons
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Recent advances in genetics and neuropathology support the idea that amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTD) are two ends of a disease spectrum. Although several animal models have been developed to investigate the pathogenesis and disease progression in ALS and FTD, there are significant limitations that hamper our ability to connect these models with the neurodegenerative processes in human diseases. With the technical breakthrough in reprogramming biology, it is now possible to generate patient-specific induced pluripotent stem cells (iPSCs) and disease-relevant neuron subtypes. This review provides a comprehensive summary of studies that use iPSC-derived neurons to model ALS and FTD. We discuss the unique capabilities of iPSC-derived neurons that capture some key features of ALS and FTD, and underscore their potential roles in drug discovery. There are, however, several critical caveats that require improvements before iPSC-derived neurons can become highly effective disease models. This article is part of a Special Issue entitled SI: Exploiting human neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 13×
“Inter-estingly, automated live microscopy shows that TDP-43 M337V b r a i n r e s e a r c h Please cite this article as: Lee, S., Huang, E.J., Modeling ALS and FTD with iPSC-derived neurons.”
InfluentialA Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409 · cited 13×
“Inter-estingly, automated live microscopy shows that TDP-43 M337V b r a i n r e s e a r c h Please cite this article as: Lee, S., Huang, E.J., Modeling ALS and FTD with iPSC-derived neurons.”
InfluentialArai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 3×
“These mutations include missense mutations in genes encoding two RNA/DNA binding proteins, TDP-43 (TARDBP or TAR-DNA-binding protein-43) and FUS/TLS (fused in sarcoma/translocation in liposarcoma or FUS) and the GGGGCC hexanucleotide expansions in C9ORF72 gene (Lee et al., 2012; Ling et al., 2013).”
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012 · cited 1×
“1) (Mackenzie et al., 2011, 2010).”
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916 · cited 2×
“This is complicated by the observations that mutations in TDP-43 gene TARDBP are quite rare in sporadic ALS cases, and that TDP-43 proteinopathy can also be identified in other neurodegenerative diseases, such as Alzheimer's disease (Amador-Ortiz et al., 2007).”
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Donnelly, C. J., Zhang, P.-W., Pham, J. T., Haeusler, A. R., Mistry, N. A., Vidensky, S., Daley, E. L., Poth, E. M., Hoover, B., Fines, D. M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.015 · Cited by 877
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670 · cited 10×
“Despite using the same reagents to characterize C9ORF72 iPSC-derived neurons, not all the studies are able to identify RAN translation protein products (Sareen et al., 2013).”
InfluentialAxonal Transport of TDP-43 mRNA Granules Is Impaired by ALS-Causing Mutations
Alami, N. H., Smith, R. B., Carrasco, M. A., Williams, L. A., Winborn, C. S., Han, S. S. W., Kiskinis, E., Winborn, B., Freibaum, B. D., Kanagaraj, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.12.018 · Cited by 660
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Lee, E. B., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3121 · Cited by 659 · cited 2×
“These mutations include missense mutations in genes encoding two RNA/DNA binding proteins, TDP-43 (TARDBP or TAR-DNA-binding protein-43) and FUS/TLS (fused in sarcoma/translocation in liposarcoma or FUS) and the GGGGCC hexanucleotide expansions in C9ORF72 gene (Lee et al., 2012; Ling et al., 2013).”
Research works printed but not linked: 46
- Arambula, 2009, A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding, Proc. Natl. Acad. Sci. USA, 106, 16068, 10.1073/pnas.0901824106 · DOI · Paper page
- Ash, 2013, Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS, Neuron, 77, 639, 10.1016/j.neuron.2013.02.004 · DOI · Paper page
- Baumer, 2010, Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations, Neurology, 75, 611, 10.1212/WNL.0b013e3181ed9cde · DOI · Paper page
- Bigio, 2012, Motor neuron disease: the C9orf72 hexanucleotide repeat expansion in FTD and ALS, Nat. Rev. Neurol., 8, 249, 10.1038/nrneurol.2012.58 · DOI
- Burkhardt, 2013, A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells, Mol. Cell Neurosci., 56, 355, 10.1016/j.mcn.2013.07.007 · DOI · Paper page
- Deng, 2014, The role of FUS gene variants in neurodegenerative diseases, Nat. Rev. Neurol., 10, 337, 10.1038/nrneurol.2014.78 · DOI · Paper page
- Devlin, 2015, Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability, Nat. Commun., 6, 5999, 10.1038/ncomms6999 · DOI · Paper page
- Egawa, 2012, Drug screening for ALS using patient-specific induced pluripotent stem cells, Sci. Transl. Med., 4, 145ra104, 10.1126/scitranslmed.3004052 · DOI · Paper page
- Espuny-Camacho, 2013, Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo, Neuron, 77, 440, 10.1016/j.neuron.2012.12.011 · DOI · Paper page
- Fenton, 2011, Functions and regulation of the 70kDa ribosomal S6 kinases, Int. J. Biochem. Cell Biol., 43, 47, 10.1016/j.biocel.2010.09.018 · DOI · Paper page
- Gendron, 2014, Mechanisms of toxicity in C9FTLD/ALS, Acta Neuropathol., 127, 359, 10.1007/s00401-013-1237-z · DOI · Paper page
- Goldman, 2005, Comparison of family histories in FTLD subtypes and related tauopathies, Neurology, 65, 1817, 10.1212/01.wnl.0000187068.92184.63 · DOI · Paper page
- Huang, 2010, Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions, Brain Pathol., 20, 1069, 10.1111/j.1750-3639.2010.00413.x · DOI · Paper page
- Jahromi, 2013, Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1, J. Med. Chem., 56, 9471, 10.1021/jm400794z · DOI
- Kwiatkowski, 2009, Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis, Science, 323, 1205, 10.1126/science.1166066 · DOI · Paper page
- Lagier-Tourenne, 2013, Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration, Proc. Natl. Acad. Sci. USA, 110, E4530, 10.1073/pnas.1318835110 · DOI · Paper page
- Lagier-Tourenne, 2010, Neurodegeneration: an expansion in ALS genetics, Nature, 466, 1052, 10.1038/4661052a · DOI
- Lattante, 2013, TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update, Hum. Mutat., 34, 812, 10.1002/humu.22319 · DOI · Paper page
- Lillo, 2011, How common are behavioural changes in amyotrophic lateral sclerosis?, Amyotroph. Lateral Scler., 12, 45, 10.3109/17482968.2010.520718 · DOI · Paper page
- Lomen-Hoerth, 2002, The overlap of amyotrophic lateral sclerosis and frontotemporal dementia, Neurology, 59, 1077, 10.1212/WNL.59.7.1077 · DOI · Paper page
- Lomen-Hoerth, 2003, Are amyotrophic lateral sclerosis patients cognitively normal?, Neurology, 60, 1094, 10.1212/01.WNL.0000055861.95202.8D · DOI · Paper page
- Mackenzie, 2011, A harmonized classification system for FTLD-TDP pathology, Acta Neuropathol., 122, 111, 10.1007/s00401-011-0845-8 · DOI · Paper page
- Millecamps, 2012, Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes, J. Med. Genet., 49, 258, 10.1136/jmedgenet-2011-100699 · DOI · Paper page
- Mori, 2013, The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS, Science, 339, 1335, 10.1126/science.1232927 · DOI · Paper page
- Mulders, 2009, Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy, Proc. Natl. Acad. Sci. USA, 106, 13915, 10.1073/pnas.0905780106 · DOI · Paper page
- Neumann, 2006, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis, Science, 314, 130, 10.1126/science.1134108 · DOI · Paper page
- Nishimura, 2014, Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells, PLoS One, 9, e91269, 10.1371/journal.pone.0091269 · DOI · Paper page
- Olive, 2009, TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies, J. Neuropathol. Exp. Neurol., 68, 262, 10.1097/NEN.0b013e3181996d8f · DOI · Paper page
- Olney, 2005, The effects of executive and behavioral dysfunction on the course of ALS, Neurology, 65, 1774, 10.1212/01.wnl.0000188759.87240.8b · DOI · Paper page
- Ou, 1995, Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, J. Virol., 69, 3584, 10.1128/JVI.69.6.3584-3596.1995 · DOI · Paper page
- Qiu, 2014, ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects, J. Clin. Invest., 124, 10.1172/JCI72723 · DOI · Paper page
- Raitano, 2015, Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia, Stem Cell Rep., 4, 16, 10.1016/j.stemcr.2014.12.001 · DOI · Paper page
- Ringholz, 2005, Prevalence and patterns of cognitive impairment in sporadic ALS, Neurology, 65, 586, 10.1212/01.wnl.0000172911.39167.b6 · DOI · Paper page
- Sareen, 2014, Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord, J. Comp Neurol., 522, 2707, 10.1002/cne.23578 · DOI · Paper page
- Sephton, 2014, Activity-dependent FUS dysregulation disrupts synaptic homeostasis, Proc. Natl. Acad. Sci. USA, 111, E4769, 10.1073/pnas.1406162111 · DOI · Paper page
- Strong, 2009, Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis, Amyotroph. Lateral Scler., 10, 131, 10.1080/17482960802654364 · DOI · Paper page
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Toma, 2015, Motoneurons derived from induced pluripotent stem cells develop mature phenotypes typical of endogenous spinal motoneurons, J. Neurosci., 35, 1291, 10.1523/JNEUROSCI.2126-14.2015 · DOI
- Vance, 2009, Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6, Science, 323, 1208, 10.1126/science.1165942 · DOI · Paper page
- Wainger, 2014, Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons, Cell Rep., 7, 1, 10.1016/j.celrep.2014.03.019 · DOI · Paper page
- Warf, 2009, Pentamidine reverses the splicing defects associated with myotonic dystrophy, Proc. Natl. Acad. Sci. USA, 106, 18551, 10.1073/pnas.0903234106 · DOI · Paper page
- Wheeler, 2012, Targeting nuclear RNA for in vivo correction of myotonic dystrophy, Nature, 488, 111, 10.1038/nature11362 · DOI · Paper page
- Wolfe, 2009, Tau mutations in neurodegenerative diseases, J. Biol. Chem., 284, 6021, 10.1074/jbc.R800013200 · DOI · Paper page
- Yan, 2010, Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia, Neurology, 75, 807, 10.1212/WNL.0b013e3181f07e0c · DOI · Paper page
- Yang, 2013, A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS, Cell Stem Cell, 12, 713, 10.1016/j.stem.2013.04.003 · DOI · Paper page
Cited by
Glucocerebrosidase and its relevance to Parkinson disease
Do, J., McKinney, C., Sharma, P., & Sidransky, E. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0336-2 · Cited by 300
Genetics of FTLD : overview and what else we can expect from genetic studies
Pottier, C., Ravenscroft, T. A., Sanchez‐Contreras, M., & Rademakers, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13622 · Cited by 148
Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
Hawrot, J., Imhof, S., & Wainger, B. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104680 · Cited by 74
Granulin loss of function in human mature brain organoids implicates astrocytes in TDP-43 pathology
de Majo, M., Koontz, M., Marsan, E., Salinas, N., Ramsey, A., Kuo, Y.-M., Seo, K., Li, H., Dräger, N., Leng, K., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.01.012 · Cited by 44
Self-citationHuman iPSC Models in Drug Discovery: Opportunities and Challenges
Silva, M. C., Cross, A., Brandon, N. J., & Haggarty, S. J. (2017) · Comprehensive Medicinal Chemistry III · doi:10.1016/b978-0-12-409547-2.12284-x · Cited by 6
Metadata
- Authors
- Lee, S., & Huang, E. J.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 1656
- Pages
- 88-97
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1917568245
- Cited by
- 77
- References
- 26
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institute of Health (OD011915)
- Veterans Administrations BLR&D Merit Review Award (I01 BX0011-8)
- Pilot Award (I21 BX1625)
- Muscular Dystrophy Association (217592)
- Consortium for Frontotemporal Dementia Research (CFR)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.